In granting bail for six months to poet Varavara Rao in the Bhima Koregaon case on medical grounds, the Bombay High Court has affirmed the principle that even the stringent provisions of an anti-terrorism law are not invincible before a prisoner’s constitutional rights. Jailed under the draconian Unlawful Activities (Prevention) Act, Mr. Rao, 82, suffered from a host of ailments, and his condition was deteriorating until he was treated at the Nanavati Hospital on the intervention of the National Human Rights Commission. The court overruled the National Investigation Agency’s objection that bail should not be granted on medical grounds once an undertrial prisoner’s bail application was rejected on merits under UAPA, as long as access to treatment in a government hospital was available. The NIA had argued that in view of the statutory bar on granting bail under Section 43D(5) of the UAPA if the accusation against a person is prima facie true, any bail given on health grounds would open
The presence of Union Health Minister Harsh Vardhan at a press conference to promote Coronil, an Ayurvedic pill promoted by Baba Ramdev’s Patanjali Ayurved, is objectionable on more than one count. Coronil is a concoction of common herbs known to Ayurveda. Since June, there have been attempts to deploy it into India’s COVID-19 management protocol. Dr Vardhan, alongside Cabinet colleague Nitin Gadkari, was at a press conference with Baba Ramdev and other promoters of Patanjali to announce a scientific publication describing the efficacy of Coronil in ridding volunteers, part of a clinical trial, of coronavirus. For one, Coronil is a product manufactured by a private company. Doctors — Harsh Vardhan is an ENT surgeon — are explicitly barred from promoting drugs of any sort. Though Dr Vardhan didn’t explicitly mention Coronil in his address at the function, what public functionaries are seen to be doing speaks louder than what they say. Baba Ramdev first claimed that his product was
After a peak of nearly 98,000 fresh daily COVID-19 cases on September 16, 2020, the number of new cases reported per day in India has seen a slow but steady decline to reach below 12,000 in mid-February. But the trajectory of the curve began to reverse in the past week following a spike in cases in a few States — Maharashtra, Punjab, Chhattisgarh and Madhya Pradesh. In Kerala, the daily fresh cases have in fact been slowly declining for over a week. The recent case decline in the State stands out against the trend since early January 2021. Kerala was contributing between 45% and 50% of India’s total daily cases for many weeks. But despite the drop to about 33% in the past week, there has been an increase in the daily fresh cases nationally — from a seven-day average of 11,100 cases in the second week of February to 12,900 cases in the last week. In the last three weeks, from less than 3,000 daily cases, the numbers in Maharashtra have been increasing, particularly so in the